PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · Orthopedics, PodiatryMedium impact

Plantar Fasciitis Treatments (CPB 0235, reviewed 2026-04-27)

Effective date
Not stated in the notice
Identified
Aug 13, 2026

Summary

Aetna considers combined steroid/anesthetic injection medically necessary for the treatment of plantar fascia when conservative treatments (such as stretching exercises, over-the-counter silicone heel shoe inserts, and 2 to 3 weeks of non-steroidal anti-inflammatory drugs) have failed. Endoscopic plantar fasciotomy is considered medically necessary as an alternative to conventional open plantar fasciotomy for members with intractable plantar fasciitis or heel spur syndrome who have failed a 6-month trial of conservative therapy. Aetna considers a list of other approaches experimental, investigational or unproven for plantar fasciitis, including extracorporeal shock-wave therapy (ESWT), botulinum toxin, dry needling, Graston technique, low-level laser therapy, platelet-rich plasma and hyaluronic acid.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Claims for CPT 20550 (injection into the plantar fascia) need documentation that conservative treatments have failed, such as stretching exercises, over-the-counter silicone heel shoe inserts, and 2 to 3 weeks of non-steroidal anti-inflammatory drugs.
02Claims for CPT 29893 (endoscopic plantar fasciotomy) need documentation of intractable plantar fasciitis or heel spur syndrome and a 6-month trial of conservative therapy that failed.
03The approaches listed as experimental, investigational or unproven for plantar fasciitis, and the listed CPT and HCPCS codes for those indications, are not covered under this policy, including ESWT, botulinum toxin, dry needling, Graston technique, low-level laser therapy, TENEX procedure, Kinesio taping, and local ozone injection.
04Heel cushions, night splints, shoe modifications, and orthopedic shoes for plantar fasciitis are not covered under plans that exclude orthopedic shoes, foot orthotics, and other supportive devices of the feet.
05Members should refer to their benefit plan documents for applicable terms and conditions.

Codes mentioned

20550298932055220553205602056127687283002889029540646406464264645774017741797035978109781428008280602806228250E0761E0769G6001G6014J0585J0586J0587J0588J0666J1030J2001P9020Q4139Q4155S8948A4570L3000L3265L3300L3649L4350L4398S8451M72.2M77.30M77.32

Original notice

Plantar Fasciitis Treatments (CPB 0235, reviewed 2026-04-27)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account